FollowMyHealth Patient Portal

Brad S. Kahl, MD

Professor, Medicine
Division of Oncology

Director, Lymphoma Program

Specialty Areas

Lymphoma
Leukemia
Hematologic Malignancies

Board Certifications

Internal Medicine
Hematology

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Lymphoma, CLL

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129
Phone: 314-747-7222

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110
Phone: 314-747-7222

Education

Education

Fellowship, Hematology: University of Wisconsin-Madison, Madison, WI 2000
Chief Medical Resident: University of Wisconsin-Madison, Madison, WI 1998
Residency, Internal Medicine: University of Wisconsin-Madison, Madison, WI 1997
Medical Degree: Tufts University School of Medicine, Boston, MA 1994
Bachelor of Science: University of Wisconsin-Madison, Madison, WI 1989

Publication & Research

Publication & Research

Letter From the Editor: Protests.
Kahl BS
Clin Adv Hematol Oncol. 2017 Dec; 15(12)892.

PMID:
    29315281
    [PubMed - in process]
Related citations


Follicular lymphoma: are we ready for a risk-adapted approach?
Kahl BS
Hematology Am Soc Hematol Educ Program. 2017 Dec 8; 2017(1)358-364. doi: 10.1182/asheducation-2017.1.358.

PMID:
    29222279
    [PubMed - in process]
Related citations


Letter from the Editor: In memory of Oliver Press, MD, PhD.
Kahl BS
Clin Adv Hematol Oncol. 2017 Nov; 15(11)806.

PMID:
    29200412
    [PubMed - in process]
Related citations


VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Chang JE, Carmichael LL, Kim K, Peterson C, Yang DT, Traynor AM, Werndli JE, Huie MS, McFarland TA, Volk M, Blank J, Callander NS, Longo WL, Kahl BS
Clin Lymphoma Myeloma Leuk. 2018 Jan; 18(1)e61-e67. doi: 10.1016/j.clml.2017.10.006.

PMID:
    29191715
    [PubMed - in process]
Related citations


NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells.
Li Y, Wang F, Lu L, Zhu F, Huang S, Nomie K, Zhang L, Yang DT, Huang W, Kahl BS, Safe S, Wang M, Rui L
Blood Cancer J. 2017 Nov 23; 7(12)632. doi: 10.1038/s41408-017-0005-z.

PMID:
    29167454
    [PubMed - in process]
Related citations


Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Wierda WG, Byrd JC, Abramson JS, Bhat S, Bociek G, Brander D, Brown J, Chanan-Khan A, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lancet J, Ma S, Malek S, Mosse C, Shadman M, Siddiqi T, Stephens D, Wagner N, Zelenetz AD, Dwyer MA, Sundar H
J Natl Compr Canc Netw. 2017 Nov; 15(11)1414-1427. doi: 10.6004/jnccn.2017.0165.

PMID:
    29118233
    [PubMed - in process]
Related citations


Letter from the Editor: How to treat Hodgkin lymphoma.
Kahl BS
Clin Adv Hematol Oncol. 2017 Oct; 15(10)722.

PMID:
    29040249
    [PubMed - in process]
Related citations


Letter From the Editor: Take back the research.
Kahl BS
Clin Adv Hematol Oncol. 2017 Aug; 15(8)567.

PMID:
    28949943
    [PubMed - in process]
Related citations


Letter From the Editor: Book club: the Panama Canal.
Kahl BS
Clin Adv Hematol Oncol. 2017 Sep; 15(9)651.

PMID:
    28949935
    [PubMed - in process]
Related citations


Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM
Cancer Cytopathol. 2018 Jan 1; 124(1)136-144. doi: 10.1002/cncr.30979.

PMID:
    28902390
    [PubMed - indexed for MEDLINE]
Related citations


Letter From the Editor: ASCO cage match: BR vs R-CHOP.
Kahl BS
Clin Adv Hematol Oncol. 2017 Jul; 15(7)502.

PMID:
    28749911
    [PubMed - in process]
Related citations


Letter From the Editor: in memory of Robert L. Comis, MD.
Kahl BS
Clin Adv Hematol Oncol. 2017 Jun; 15(6)427.

PMID:
    28749901
    [PubMed - in process]
Related citations


Letter From the Editor: Affordable Care?
Kahl BS
Clin Adv Hematol Oncol. 2017 Apr; 15(4)227.

PMID:
    28591095
    [PubMed - in process]
Related citations


Letter From the Editor: Buyer Beware!
Kahl BS
Clin Adv Hematol Oncol. 2017 May; 15(5)318.

PMID:
    28591088
    [PubMed - in process]
Related citations


Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies.
Cohen JB, Zain JM, Kahl BS
Am Soc Clin Oncol Educ Book. 2017; 37512-525. doi: 10.14694/EDBK_175448.

PMID:
    28561694
    [PubMed - indexed for MEDLINE]
Related citations


Letter From the Editor: Inauguration week.
Kahl BS
Clin Adv Hematol Oncol. 2017 Feb; 15(2)86.

PMID:
    28398277
    [PubMed - in process]
Related citations


Letter From the Editor: When will we beat R-CHOP?
Kahl BS
Clin Adv Hematol Oncol. 2017 Mar; 15(3)159.

PMID:
    28398269
    [PubMed - in process]
Related citations


Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
Gopal AK, Kahl BS, Flowers CR, Martin P, Ansell SM, Abella-Dominicis E, Koh B, Ye W, Barr PM, Salles GA, Friedberg JW
Blood. 2017 Jun 1; 129(22)3037-3039. doi: 10.1182/blood-2016-12-757740.

PMID:
    28325864
    [PubMed - indexed for MEDLINE]
Related citations


Letter From the Editor: The ASH rehash.
Kahl BS
Clin Adv Hematol Oncol. 2017 Jan; 15(1)7.

PMID:
    28212364
    [PubMed - indexed for MEDLINE]
Related citations


Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM
Clin Lymphoma Myeloma Leuk. 2017 Apr; 17(4)193-200. doi: 10.1016/j.clml.2016.10.001.

PMID:
    28209473
    [PubMed - indexed for MEDLINE]
Related citations

Areas of Research Interest

Developing new and better treatment approaches to lymphoma and chronic lymphocytic leukemia.